COMMENTARYProspective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation
References (20)
- et al.
The course of patients after variceal haemorrhage
Gastroenterology
(1981) - et al.
Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices
Lancet
(1993) - et al.
Endoscopic ligation of oesophageal varices compared with injection sclerotherapy: a prospective randomized trial
Gastrointest Endosc
(1993) - et al.
Octreotide infusion or emergency sclerotherapy for variceal haemorrhage
Lancet
(1993) - et al.
Initial results of a randomized, prospective study of combination banding and sclerotherapy vs sclerotherapy alone for haemostasis of bleeding oesophagogastric varices
Gastrointest Endosc
(1995) - et al.
Randomized comparison of ligation vs ligation plus sclerotherapy for oesophageal variceal bleeding
Gastromtest Endosc
(1995) - et al.
Effect of somatostatin on splanchnic haemodynamics in patients with cirrhosis of the liver and in normal subjects
Gastroenterology
(1981) - et al.
A prospective randomized controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices
J Hepatol
(1992) - et al.
Cirrhotics with variceal haemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates
Hepatology
(1989)
There are more references available in the full text version of this article.
Cited by (196)
Management of liver failure in general intensive care unit
2020, Anaesthesia Critical Care and Pain MedicineCitation Excerpt :Splanchnic vasoconstrictor agents such as somatostatin, octreotide and terlipressin exert their vasoactive effects and decrease splanchnic blood flow and portal pressure. In patients with acute variceal bleeding who are undergoing endoscopic sclerotherapy, several studies showed that the early intravenous administration of a vasoactive agent was more effective than placebo in the overall control of haemorrhage [173–175]. In one meta-analysis published in 2012 [176], the use of vasoactive agents was associated with a significantly lower risk of mortality at 7 days (RR 0.74; 95% CI 0.57–0.95; P = 0.02), fewer transfusion requirements and a shorter duration of hospitalisation.
Endoscopic management of acute esophageal variceal bleeding
2017, Techniques in Gastrointestinal EndoscopyAddition of Somatostatin After Successful Endoscopic Variceal Ligation Does not Prevent Early Rebleeding in Comparison to Placebo: A Double Blind Randomized Controlled Trial
2015, Journal of Clinical and Experimental HepatologyOne in four patients with gastrointestinal bleeding develops shock or hemodynamic instability: A systematic review and meta-analysis
2023, World Journal of GastroenterologyCurrent Pharmacological Management in Upper Gastrointestinal Bleeding
2023, Proceedings of the Shevchenko Scientific Society. Medical Sciences
Copyright © 1995 Published by Elsevier Ltd.